Literature DB >> 7945608

A comprehensive review of naloxone for the emergency physician.

J M Chamberlain1, B L Klein.   

Abstract

Naloxone has enjoyed long-standing success as a safe and effective opioid antagonist and has been invaluable in defining the role of endogenous opioid pathways in the response to pathological states such as sepsis and hypovolemia. We look forward to exciting research to further elucidate these pathways and to improve outcome by modulating the patient's physiological response to these stresses.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7945608     DOI： 10.1016/0735-6757(94)90033-7

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


  26 in total

Review 1.  Strategies for preventing heroin overdose.

Authors:  Karl A Sporer
Journal:  BMJ       Date:  2003-02-22

Review 2.  Options and Considerations for Procedural Sedation in Pediatric Imaging.

Authors:  John W Berkenbosch
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

Review 3.  Naloxone in opioid poisoning: walking the tightrope.

Authors:  S F J Clarke; P I Dargan; A L Jones
Journal:  Emerg Med J       Date:  2005-09       Impact factor: 2.740

Review 4.  Clinical applications of commonly used contemporary antidotes. A US perspective.

Authors:  C A Bowden; E P Krenzelok
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

5.  Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration.

Authors:  Corey S Davis; Derek Carr; Jessica K Southwell; Leo Beletsky
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

6.  Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts.

Authors:  Corey S Davis; Sarah Ruiz; Patrick Glynn; Gerald Picariello; Alexander Y Walley
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

7.  Co-prescribing naloxone does not increase liability risk.

Authors:  Corey S Davis; Scott Burris; Leo Beletsky; Ingrid Binswanger
Journal:  Subst Abus       Date:  2016 Oct-Dec       Impact factor: 3.716

8.  Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018.

Authors:  Traci C Green; Corey Davis; Ziming Xuan; Alexander Y Walley; Jeffrey Bratberg
Journal:  Am J Public Health       Date:  2020-04-16       Impact factor: 9.308

9.  Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.

Authors:  Christopher Rowe; Glenn-Milo Santos; Eric Vittinghoff; Eliza Wheeler; Peter Davidson; Philip O Coffin
Journal:  Addiction       Date:  2015-08       Impact factor: 6.526

10.  Overdose prevention and naloxone prescription for opioid users in San Francisco.

Authors:  Lauren Enteen; Joanna Bauer; Rachel McLean; Eliza Wheeler; Emalie Huriaux; Alex H Kral; Joshua D Bamberger
Journal:  J Urban Health       Date:  2010-12       Impact factor: 3.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.